𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer

✍ Scribed by Motoki Miyazawa; Ryuji Ohsawa; Takuya Tsunoda; Seiko Hirono; Manabu Kawai; Masaji Tani; Yusuke Nakamura; Hiroki Yamaue

Book ID
108586590
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
641 KB
Volume
101
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imatinib mesylate for targeting the plat
Imatinib mesylate for targeting the platelet-derived growth factor β receptor in combination with fluorouracil and leucovorin in patients with refractory pancreatic, bile duct, colorectal, or gastric cancer—A dose-escalation Phase I trial
✍ Salah-Eddin Al-Batran; Akin Atmaca; Eberhard Schleyer; Claudia Pauligk; Christia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

## Abstract ## BACKGROUND. In previous experimental models, because of its ability to inhibit the activity of platelet‐derived growth factor β receptor, imatinib decreased the interstitial fluid pressure and improved the delivery and efficacy of anticancer drugs, including fluorouracil. The object